Skip to main content
. 2024 Oct 11;14(12):8196–8210. doi: 10.21037/qims-24-1072

Figure 5.

Figure 5

Nomogram for the detection of csPCa and performance evaluation in the training cohort. (A) Nomogram; (B) biopsy strategy combining the nomogram; (C) receiver operating characteristic curve; (D) calibration curve; (E) decision curve. csPCa, clinically significant prostate cancer; PI-RADS, Prostate Imaging Reporting and Data System; ADC, apparent diffusion coefficient; MRI, magnetic resonance imaging; AUC, area under the curve; CI, confidence interval.